RTW INVESTMENTS, LP

Holdings History for ACADIA PHARMACEUTICALS INC - Common Stock, $0.0001 par value per share (ACAD)

Symbol: ACAD on Nasdaq
Investment type: Equity / Common Stock, $0.0001 par value per share
Latest Disclosed Shares Owned: 7,144,524 shares
Security Ownership %: 4.2%

Shares, Excluding Options vs Price

Value, Excluding Options

RTW Investments, LP ownership in ACADIA PHARMACEUTICALS INC Common Stock, $0.0001 par value per share (ACAD)

14 Nov 2025 - RTW Investments, LP has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 7,144,524 shares of ACADIA PHARMACEUTICALS INC Common Stock, $0.0001 par value per share (ACAD). This represents 4.2% ownership of the company. In their previous filing dated 14 Feb 2025, RTW INVESTMENTS, LP had reported owning 8,705,501 shares, indicating a decrease of +18%. .

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filing time
RTW Investments, LP	4.2%	-20%	$152,464,142	7,144,524	-1,560,977	-18%	$21.34	13G/A	30 Sep 2025	14 Nov 2025, 08:16
RTW Investments, LP	5.2%		$128,232,030	8,705,501			$14.73	13G/A	31 Dec 2024	14 Feb 2025, 09:00

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	1.9%	0%	$190,830,236	7,144,524	0		$26.71	Q4 2025
30 Sep 2025	1.9%	-0.49%	$152,464,142	7,144,524	-1,851,023	-21%	$21.34	Q3 2025
30 Jun 2025	2.8%	+0.14%	$194,033,949	8,995,547	+455,430	+5.3%	$21.57	Q2 2025
31 Mar 2025	2.2%	-0.04%	$141,851,343	8,540,117	-165,384		$16.61	Q1 2025
31 Dec 2024	2.4%	-1.4%	$159,745,943	8,705,501	-5,002,005	-36%	$18.35	Q4 2024
30 Sep 2024	3.1%	0%	$210,821,442	13,707,506	0		$15.38	Q3 2024
30 Jun 2024	3.4%	-0.03%	$222,746,973	13,707,506	-121,809	-0.88%	$16.25	Q2 2024
31 Mar 2024	3.8%	+0.7%	$255,704,034	13,829,315	+2,575,764	+23%	$18.49	Q1 2024
31 Dec 2023	5.5%	-0.16%	$352,348,682	11,253,551	-322,986	-2.8%	$31.31	Q4 2023
30 Sep 2023	5.1%	+0.79%	$241,255,031	11,576,537	+1,793,288	+18%	$20.84	Q3 2023
30 Jun 2023	4.5%	+0.7%	$234,308,814	9,783,249	+1,540,385	+19%	$23.95	Q2 2023
31 Mar 2023	3.2%	+1.8%	$155,130,700	8,242,864	+4,571,926	+125%	$18.82	Q1 2023
31 Dec 2022	1.2%	0%	$58,441,333	3,670,938	0		$15.92	Q4 2022
30 Sep 2022	1.4%	-0.21%	$60,057,000	3,670,938	-553,171	-13%	$16.36	Q3 2022
30 Jun 2022	1.5%	+1.5%	$59,518,000	4,224,109	+4,224,109	NEW	$14.09	Q2 2022

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.